The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we've gone far beyond heart disease with this drug we're looking at Alzheimer's age-related macular degeneration septicemia and diabetes because if you really inhibit CTP you not only stop the transfer from cholesterol from HDL to LDL but you completely change lipoprotein metabolism
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.